CD4 and cutaneous melanoma: In light of recent research emphasising the critical role of MHC II‐dependent CD4+ T‐cell immunity in combating cutaneous melanoma,63, 64 we deeper analysed the interplay between RECQL4 and MHC‐II‐associated molecules.